July 14, 2010 ·
Leave a comment
Brian Castle joined Thought Leader Select in January of 2010, as director of global marketing and client relations. Brian has 12 years of experience leading teams in business development, sales, marketing and customer services. He spent 11 years in the financial services industry, managing business units for several top banking institutions. Upon leaving the financial sector, Brian used his expertise in business development, communications and marketing to help business and non-profit clients develop and execute marketing, social media and branding strategies. In his new role at Thought Leader Select, Brian is helping the company expand its sales and marketing efforts and create a larger presence in the KOL identification and profiling marketplace.
The Thought Leader Select Blog sat down with Brian, the powerhouse behind Thought Leader Select’s social media strategy, to learn more about his role within the company, what drives him at work and the extracurricular passions that make him unique.
TLS Blog: Good morning, Brian. What made you sign on with Thought Leader Select?
Brian Castle: I spent most of my career working in the financial services industry. When the industry started experiencing its recent turmoil, I decided it was time to make a change. So I reached out to several business owners and started collaborating with them on a host of projects in marketing, business development, social media, and public ... read more »
TAGS:
banking
biotechnology
business development
communications
customer services
financial services
health care
hockey
key opinion leaders
KOL deployment
KOL development
KOL engagement
KOL identification
KOL mapping
KOL profiling
KOLs
Kristen Smithwick
Lisa Smith
marketing
medical device
non profit
objective research
Paul Meade
pharmaceutical
pop culture
public relations
RBC
rock star
sales
social media
Thought Leader Select
thought leaders
wachovia
wells fargo
June 16, 2010 ·
Leave a comment
Daniel Bagi joined Thought Leader Select to steer the company’s business development efforts in Latin America in the spring of 2010. With over two decades working for pharmaceutical and biotechnology companies, Dr. Bagi brings a high level of industry expertise to his consulting work with Thought Leader Select’s clients and prospects.
Daniel earned a Doctor of Medicine degree from the University of Monterrey (Mexico), and he has served the industry in a variety of capacities, including product development, regulatory affairs, licensing, and business development. He directed global clinical development for a suite of anti-cancer drug therapies at Lorus Therapeutics of Markham, Ontario and IGT Pharma of Vancouver, British Columbia.
More recently, Dr. Bagi has served as a senior consultant to EM Diagnostics, a US-based breast cancer diagnostic company, and, since 2005, he has served as a medical consultant to Riso Pharma Tech, a Toronto company dedicated to developing pharmaceuticals for Latin America and the Middle East.
TLS Blog: Good morning, Daniel. Please tell us why you decided to join us at Thought Leader Select.
Daniel Bagi: For me, one of the most important aspects of any professional endeavor is the work environment, which is defined by the attitudes and expertise of your colleagues. Negativity can cause failure. I was first approached by Neil Mellor (principal business development agent for North America), and Neil is ... read more »
TAGS:
anti-cancer drug therapies
biotechnology
breast cancer
business development
Daniel Bagi
Doctor of Medicine
EM Diagnostics
IGT Pharma
investment banking
key opinion leaders
KOL engagement
KOL identification
KOL profiling
KOLs
Latin America
liberal arts
Lorus Therapeutics
medical experts
medical school
Neil Mellor
Paul Meade
pharmaceutical
pharmaceutical licensing
product development
regulatory affairs
Riso Pharma Tech
tennis
Thought Leader Select
thought leaders
University of Monterrey
University of Toronto